PDS Biotechnology
PDSB
PDSB
64 hedge funds and large institutions have $89.3M invested in PDS Biotechnology in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 19 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
36% more funds holding
Funds holding: 47 → 64 (+17)
5.72% more ownership
Funds ownership: 18.2% → 23.92% (+5.7%)
Holders
64
Holding in Top 10
1
Calls
$12.1M
Puts
$2.51M
Top Buyers
| 1 | +$5.96M | |
| 2 | +$4.36M | |
| 3 | +$4.29M | |
| 4 |
Morgan Stanley
New York
|
+$2.75M |
| 5 |
Two Sigma Investments
New York
|
+$2.62M |
Top Sellers
| 1 | -$1.51M | |
| 2 | -$1.21M | |
| 3 | -$990K | |
| 4 |
NLVP
New Leaf Venture Partners
New York
|
-$348K |
| 5 |
BlackRock
New York
|
-$242K |